APA (7th ed.) Citation

CL, B., D, T., ST, B., D, J., MC, L., P, M., . . . A, M. (2025). Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 Study. The American journal of gastroenterology. https://doi.org/10.14309/ajg.0000000000003853

Chicago Style (17th ed.) Citation

CL, Bowlus, et al. "Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 Study." The American Journal of Gastroenterology 2025. https://doi.org/10.14309/ajg.0000000000003853.

MLA (9th ed.) Citation

CL, Bowlus, et al. "Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 Study." The American Journal of Gastroenterology, 2025, https://doi.org/10.14309/ajg.0000000000003853.